Ranbaxy Labs marks 20th year in Ukraine

Indian drug maker has become top player in $3.7 billion market

GURGAON, India — Ranbaxy Labs is celebrating the 20th anniversary of its operations in Ukraine, the Indian generic drug maker said Wednesday.

The drug maker established a base in the eastern European country in 1993 and has since become the largest drug company in the market, whose value is estimated at $3.7 billion, according to the company. Ranbaxy's products in Ukraine include branded and generic drugs.

"Ranbaxy has been providing high-quality, affordable generic medicines to the citizens of Ukraine for the last two decades, thereby supporting the government to bring down healthcare costs," Ranbaxy CEO and managing director Arun Sawhney said. "We remain committed to the Ukraine market and its people and will continue to operate for our paradigm of quality and patients first."

Poll

Poll

SPECIAL REPORTS

Are we in the midst of a beauty revolution? Perhaps. It is no secret that the ever-changing beauty category is all about trends, but one could argue that we are embarking on an especially interesting time in beauty as technology is changing the way consumers shop and new innovations strive to break through the noise.

In this beauty report, Drug Store News takes a deeper dive into some of the leading trends that are reshaping beauty.more ...

IN THIS ISSUE

In this issue, DSN examines PricewaterhouseCoopers' "Top Health Industry Issues for 2015;" takes you on a tour of Murad, shares beauty trends and insights and delves into location-based technology and how it is revolutionizing health, retail.Click here to view the issue.